Harvard Bioscience Files 8-K on Officer Changes and Shareholder Votes
Ticker: HBIO · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1123494
| Field | Detail |
|---|---|
| Company | Harvard Bioscience Inc (HBIO) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, shareholder-vote
TL;DR
Harvard Bioscience 8-K: Leadership changes, director elections, and shareholder votes filed May 30, 2025.
AI Summary
Harvard Bioscience, Inc. filed an 8-K on May 30, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits. The company is based in Holliston, MA.
Why It Matters
This filing provides crucial updates on the company's leadership and governance, which can impact investor confidence and strategic direction.
Risk Assessment
Risk Level: low — This is a routine 8-K filing detailing corporate governance and officer changes, not indicating immediate financial distress or significant operational shifts.
Key Players & Entities
- HARVARD BIOSCIENCE, INC. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Holliston, MA (location) — Principal Executive Offices
- May 30, 2025 (date) — Date of earliest event reported
FAQ
What specific officer positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers', but the specific positions are not detailed in the provided excerpt.
Were there any specific matters submitted to a vote of security holders on or around May 30, 2025?
Yes, the filing explicitly states 'Submission of Matters to a Vote of Security Holders' as an item covered.
What is the primary business of Harvard Bioscience, Inc. according to the filing?
The filing lists the Standard Industrial Classification as 'LABORATORY ANALYTICAL INSTRUMENTS [3826]'.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated May 30, 2025.
What is the address of Harvard Bioscience, Inc.'s principal executive offices?
The principal executive offices are located at 84 October Hill Road, Holliston, MA 01746.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding HARVARD BIOSCIENCE INC (HBIO).